Compare WIX & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WIX | STVN |
|---|---|---|
| Founded | 2006 | 1949 |
| Country | Israel | Italy |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.2B |
| IPO Year | 2013 | 2021 |
| Metric | WIX | STVN |
|---|---|---|
| Price | $90.11 | $15.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 4 |
| Target Price | ★ $156.95 | $25.13 |
| AVG Volume (30 Days) | ★ 2.5M | 636.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.55 | $10.26 |
| Revenue Next Year | $13.24 | $10.02 |
| P/E Ratio | $28.86 | ★ $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.22 | $13.91 |
| 52 Week High | $190.92 | $28.00 |
| Indicator | WIX | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 42.55 |
| Support Level | $75.00 | $14.03 |
| Resistance Level | $96.82 | $16.69 |
| Average True Range (ATR) | 4.71 | 0.89 |
| MACD | 3.60 | 0.11 |
| Stochastic Oscillator | 86.36 | 25.25 |
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.